4//SEC Filing
BIOSANTE PHARMACEUTICALS INC 4
Accession 0001235802-04-000220
$ANIPCIK 0001023024operating
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 8:34 PM ET
Size
4.9 KB
Accession
0001235802-04-000220
Insider Transaction Report
Form 4
LEHMAN LEAH M
VP, Product Development
Transactions
- Sale
Common Stock
2004-11-30$10.07/sh−50,000$503,500→ 109,777 total
Documents
Issuer
BIOSANTE PHARMACEUTICALS INC
CIK 0001023024
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001023024
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 8:34 PM ET
- Size
- 4.9 KB